Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Drendel

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
EJNMMI Research|March 8, 2020
Results from extended lymphadenectomies with [<sup>111</sup>In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancerCordula A Jilg, Kathrin Reichel, Christian Stoykow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Detection Rate of <sup>18</sup>F-Choline PET/CT and <sup>68</sup>Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph NodesCordula A Jilg, Vanessa Drendel, H Christian Rischke, et al.
Oncotarget|December 17, 2014
Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneityMalte Krönig, Max Walter, Vanessa Drendel, et al.
Theranostics|July 23, 2016
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise ComparisonConstantinos Zamboglou, Florian Schiller, Tobias Fechter, et al.
Proteomics. Clinical Applications|June 4, 2014
Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissuePeter Bronsert, Juliane Weißer, Martin L Biniossek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2017
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology referenceConstantinos Zamboglou, Ilias Sachpazidis, Khodor Koubar, et al.
Theranostics|July 23, 2016
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PETChristian Stoykow, Thalia Erbes, Helmut R Maecke, et al.
Oncotarget|December 16, 2014
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsCordula A Jilg, Anett Ketscher, Eric Metzger, et al.
Biomed Research International|December 20, 2016
Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative MenMalte Kroenig, Kathrin Schaal, Matthias Benndorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2017
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist <sup>68</sup>Ga-RM2: Preliminary results in patients with negative or inconclusive [<sup>18</sup>F]Fluoroethylcholine-PET/CTGesche Wieser, Ilinca Popp, H Christian Rischke, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
EJNMMI Research|March 8, 2020
Results from extended lymphadenectomies with [<sup>111</sup>In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancerCordula A Jilg, Kathrin Reichel, Christian Stoykow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Detection Rate of <sup>18</sup>F-Choline PET/CT and <sup>68</sup>Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph NodesCordula A Jilg, Vanessa Drendel, H Christian Rischke, et al.
Oncotarget|December 17, 2014
Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneityMalte Krönig, Max Walter, Vanessa Drendel, et al.
Theranostics|July 23, 2016
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise ComparisonConstantinos Zamboglou, Florian Schiller, Tobias Fechter, et al.
Proteomics. Clinical Applications|June 4, 2014
Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissuePeter Bronsert, Juliane Weißer, Martin L Biniossek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2017
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology referenceConstantinos Zamboglou, Ilias Sachpazidis, Khodor Koubar, et al.
Theranostics|July 23, 2016
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PETChristian Stoykow, Thalia Erbes, Helmut R Maecke, et al.
Oncotarget|December 16, 2014
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsCordula A Jilg, Anett Ketscher, Eric Metzger, et al.
Biomed Research International|December 20, 2016
Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative MenMalte Kroenig, Kathrin Schaal, Matthias Benndorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2017
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist <sup>68</sup>Ga-RM2: Preliminary results in patients with negative or inconclusive [<sup>18</sup>F]Fluoroethylcholine-PET/CTGesche Wieser, Ilinca Popp, H Christian Rischke, et al.
Pageof 3